FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387176957> ?p ?o ?g. }

• W4387176957 endingPage "1542" @default.
• W4387176957 startingPage "1542" @default.
• W4387176957 abstract "Chicken melanoma differentiation-associated gene 5 (MDA5) is a member of the RLRs family that recognizes the viral RNAs invading cells and activates downstream interferon regulatory pathways, thereby inhibiting viral replication. The caspase activation and recruitment domain (CARD) is the most important region in MDA5 protein. However, the antiviral and immune enhancement of MDA5 with the CARD region remains unclear. In this study, two truncated MDA5 genes with different CARD regions, namely MDA5-1 with CARD1 plus partial CARD2 domain and MDA5-2 with CARD1 plus complete CARD2 domain, were cloned via reverse transcription PCR and ligated into plasmid Flag-N vector to be Flag-MDA5-1 and Flag-MDA5-2 plasmids. DF-1 cells were transfected with two plasmids for 24 h and then inoculated with H9N2 virus (0.1 MOI) for 6 h to detect the levels of IFN-β, PKR, MAVS, and viral HA, NA, and NS proteins expression. The results showed that MDA5-1 and MDA5-2 increased the expression of IFN-β and PKR, activated the downstream molecule MAVS production, and inhibited the expression of HA, NA, and NS proteins. The knockdown of MDA5 genes confirmed that MDA5-2 had a stronger antiviral effect than that of MDA5-1. Furthermore, the recombinant proteins MDA5-1 and MDA5-2 were combined with H9N2 inactivated vaccine to immunize SPF chickens subcutaneously injected in the neck three times. The immune response of the immunized chicken was investigated. It was observed that the antibody titers and expressions of immune-related molecules from the chicken immunized with MDA5-1 and MDA5-2 group were increased, in which the inducing function of MDA5-2 groups was the highest among all immunization groups. These results suggested that the truncated MDA5 recombinant proteins with complete CARD2 region could play vital roles in antiviral and immune enhancement. This study provides important material for the further study of the immunoregulatory function and clinical applications of MDA5 protein." @default.
• W4387176957 created "2023-09-30" @default.
• W4387176957 creator A5003462637 @default.
• W4387176957 creator A5025139149 @default.
• W4387176957 creator A5030992210 @default.
• W4387176957 creator A5031465676 @default.
• W4387176957 creator A5036906162 @default.
• W4387176957 creator A5038339911 @default.
• W4387176957 creator A5066977468 @default.
• W4387176957 creator A5072363031 @default.
• W4387176957 creator A5083972651 @default.
• W4387176957 date "2023-09-28" @default.
• W4387176957 modified "2023-10-11" @default.
• W4387176957 title "MDA5 with Complete CARD2 Region Inhibits the Early Replication of H9N2 AIV and Enhances the Immune Response during Vaccination" @default.
• W4387176957 cites W1518989519 @default.
• W4387176957 cites W1583708762 @default.
• W4387176957 cites W1622989995 @default.
• W4387176957 cites W1979838502 @default.
• W4387176957 cites W1987311941 @default.
• W4387176957 cites W2004312418 @default.
• W4387176957 cites W2006406228 @default.
• W4387176957 cites W2033474198 @default.
• W4387176957 cites W2036525828 @default.
• W4387176957 cites W2054260242 @default.
• W4387176957 cites W2082632613 @default.
• W4387176957 cites W2084034225 @default.
• W4387176957 cites W2091129202 @default.
• W4387176957 cites W2120483717 @default.
• W4387176957 cites W2126982616 @default.
• W4387176957 cites W2138651252 @default.
• W4387176957 cites W2141179685 @default.
• W4387176957 cites W2144887013 @default.
• W4387176957 cites W2160183598 @default.
• W4387176957 cites W2300738269 @default.
• W4387176957 cites W2652888557 @default.
• W4387176957 cites W2767589352 @default.
• W4387176957 cites W2957468385 @default.
• W4387176957 cites W3036395785 @default.
• W4387176957 cites W3042928905 @default.
• W4387176957 cites W3202049465 @default.
• W4387176957 cites W3205293336 @default.
• W4387176957 cites W4200565295 @default.
• W4387176957 cites W4233279702 @default.
• W4387176957 cites W4280504184 @default.
• W4387176957 cites W4289169689 @default.
• W4387176957 cites W4296094416 @default.
• W4387176957 cites W4320731115 @default.
• W4387176957 cites W4365515859 @default.
• W4387176957 cites W4380872708 @default.
• W4387176957 doi "https://doi.org/10.3390/vaccines11101542" @default.
• W4387176957 hasPublicationYear "2023" @default.
• W4387176957 type Work @default.
• W4387176957 citedByCount "0" @default.
• W4387176957 crossrefType "journal-article" @default.
• W4387176957 hasAuthorship W4387176957A5003462637 @default.
• W4387176957 hasAuthorship W4387176957A5025139149 @default.
• W4387176957 hasAuthorship W4387176957A5030992210 @default.
• W4387176957 hasAuthorship W4387176957A5031465676 @default.
• W4387176957 hasAuthorship W4387176957A5036906162 @default.
• W4387176957 hasAuthorship W4387176957A5038339911 @default.
• W4387176957 hasAuthorship W4387176957A5066977468 @default.
• W4387176957 hasAuthorship W4387176957A5072363031 @default.
• W4387176957 hasAuthorship W4387176957A5083972651 @default.
• W4387176957 hasBestOaLocation W43871769571 @default.
• W4387176957 hasConcept C104317684 @default.
• W4387176957 hasConcept C134474686 @default.
• W4387176957 hasConcept C140704245 @default.
• W4387176957 hasConcept C153911025 @default.
• W4387176957 hasConcept C159047783 @default.
• W4387176957 hasConcept C166703698 @default.
• W4387176957 hasConcept C203014093 @default.
• W4387176957 hasConcept C2522874641 @default.
• W4387176957 hasConcept C2776178377 @default.
• W4387176957 hasConcept C54009773 @default.
• W4387176957 hasConcept C55493867 @default.
• W4387176957 hasConcept C67705224 @default.
• W4387176957 hasConcept C86803240 @default.
• W4387176957 hasConcept C8891405 @default.
• W4387176957 hasConcept C89423630 @default.
• W4387176957 hasConceptScore W4387176957C104317684 @default.
• W4387176957 hasConceptScore W4387176957C134474686 @default.
• W4387176957 hasConceptScore W4387176957C140704245 @default.
• W4387176957 hasConceptScore W4387176957C153911025 @default.
• W4387176957 hasConceptScore W4387176957C159047783 @default.
• W4387176957 hasConceptScore W4387176957C166703698 @default.
• W4387176957 hasConceptScore W4387176957C203014093 @default.
• W4387176957 hasConceptScore W4387176957C2522874641 @default.
• W4387176957 hasConceptScore W4387176957C2776178377 @default.
• W4387176957 hasConceptScore W4387176957C54009773 @default.
• W4387176957 hasConceptScore W4387176957C55493867 @default.
• W4387176957 hasConceptScore W4387176957C67705224 @default.
• W4387176957 hasConceptScore W4387176957C86803240 @default.
• W4387176957 hasConceptScore W4387176957C8891405 @default.
• W4387176957 hasConceptScore W4387176957C89423630 @default.
• W4387176957 hasFunder F4320335777 @default.
• W4387176957 hasIssue "10" @default.
• W4387176957 hasLocation W43871769571 @default.
• W4387176957 hasOpenAccess W4387176957 @default.

• next